MARCUCCI, ROSSELLA
 Distribuzione geografica
Continente #
NA - Nord America 25.899
EU - Europa 20.794
AS - Asia 11.823
SA - Sud America 1.880
AF - Africa 322
OC - Oceania 208
Continente sconosciuto - Info sul continente non disponibili 12
Totale 60.938
Nazione #
US - Stati Uniti d'America 25.575
PL - Polonia 6.066
RU - Federazione Russa 5.359
IT - Italia 4.237
SG - Singapore 3.428
CN - Cina 2.632
HK - Hong Kong 1.681
BR - Brasile 1.527
VN - Vietnam 1.364
IE - Irlanda 1.263
KR - Corea 1.072
SE - Svezia 966
DE - Germania 666
FI - Finlandia 525
FR - Francia 513
UA - Ucraina 422
IN - India 370
GB - Regno Unito 339
BD - Bangladesh 306
AU - Australia 206
CA - Canada 179
ID - Indonesia 174
JP - Giappone 157
JO - Giordania 138
AR - Argentina 136
NL - Olanda 129
TR - Turchia 99
IQ - Iraq 81
MX - Messico 74
ES - Italia 68
CI - Costa d'Avorio 64
EC - Ecuador 64
ZA - Sudafrica 48
PK - Pakistan 47
BE - Belgio 42
MA - Marocco 40
CH - Svizzera 39
SA - Arabia Saudita 36
NG - Nigeria 34
CO - Colombia 33
PY - Paraguay 32
VE - Venezuela 31
CZ - Repubblica Ceca 26
TN - Tunisia 26
TW - Taiwan 26
UZ - Uzbekistan 25
AT - Austria 24
CL - Cile 23
PE - Perù 20
PH - Filippine 20
DZ - Algeria 18
OM - Oman 17
SC - Seychelles 17
EG - Egitto 16
JM - Giamaica 16
KE - Kenya 16
MY - Malesia 15
AE - Emirati Arabi Uniti 14
NP - Nepal 14
AZ - Azerbaigian 12
BJ - Benin 12
LT - Lituania 12
UY - Uruguay 12
RO - Romania 11
SK - Slovacchia (Repubblica Slovacca) 11
HN - Honduras 10
CR - Costa Rica 9
IL - Israele 9
KG - Kirghizistan 9
AL - Albania 8
KZ - Kazakistan 8
TH - Thailandia 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
GE - Georgia 7
GR - Grecia 7
IR - Iran 7
MM - Myanmar 7
RS - Serbia 7
SN - Senegal 7
TT - Trinidad e Tobago 7
LB - Libano 6
LV - Lettonia 6
PA - Panama 6
A1 - Anonimo 5
BY - Bielorussia 5
DK - Danimarca 5
HR - Croazia 5
MU - Mauritius 5
PS - Palestinian Territory 5
QA - Qatar 5
UG - Uganda 5
ET - Etiopia 4
GT - Guatemala 4
HU - Ungheria 4
NO - Norvegia 4
PT - Portogallo 4
SI - Slovenia 4
AM - Armenia 3
BH - Bahrain 3
Totale 60.877
Città #
Warsaw 6.052
Santa Clara 4.848
Ashburn 3.105
Singapore 2.431
Fairfield 2.378
Hong Kong 1.390
Dublin 1.258
Chandler 1.115
Woodbridge 1.109
Seoul 1.052
Seattle 985
Houston 875
Cambridge 826
Wilmington 815
San Jose 805
Milan 699
Florence 642
Jacksonville 608
Beijing 565
Hefei 524
Los Angeles 441
Ann Arbor 429
Ho Chi Minh City 421
Altamura 418
Lawrence 405
Princeton 356
Rome 340
Lauterbourg 326
Buffalo 319
Moscow 284
The Dalles 280
Hanoi 277
Council Bluffs 262
Dallas 243
Boston 227
New York 224
Helsinki 200
Mumbai 200
Medford 189
Boardman 184
Melbourne 180
Munich 178
San Diego 144
Tokyo 144
São Paulo 131
Shanghai 130
Jakarta 122
Naples 103
Kent 101
Paris 88
Clifton 79
Turin 77
Dong Ket 76
Frankfurt am Main 76
Orem 75
London 73
Da Nang 69
Phoenix 69
Bologna 66
Norwalk 66
Turku 64
Abidjan 63
Falls Church 58
Chicago 56
Redondo Beach 56
Haiphong 55
Toronto 55
Palermo 51
Amsterdam 49
Montreal 47
Lappeenranta 46
Rio de Janeiro 46
Figino 40
Guangzhou 40
Izmir 39
Belo Horizonte 38
Atlanta 36
Brooklyn 36
Brussels 36
Andover 34
Chennai 34
Hillsboro 34
Miano 34
Nuremberg 34
Yubileyny 33
Brasília 32
San Francisco 32
Bari 31
Denver 31
Tianjin 29
Abuja 28
Baghdad 28
Bern 28
Hải Dương 28
Shenzhen 28
Venice 27
Verona 27
Bengaluru 26
Columbus 25
Curitiba 24
Totale 41.692
Nome #
Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events. A meta-analysis 633
Validation of a literature-based adherence score to Mediterranean diet: the MEDI-LITE score 435
A khorasan wheat-based replacement diet improves risk profile of patients with type 2 diabetes mellitus (T2DM): a randomized crossover trial 416
High-throughput multiplex single-nucleotide polymorphism (SNP) analysis in genes involved in methionine metabolism 386
CLOCK gene polymorphisms and quality of aging in a cohort of nonagenarians – The MUGELLO Study 385
Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion 380
High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers. 360
Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. 356
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 355
High platelet turnover and reactivity in renal transplant recipients patients 347
Clinical events beyond one year after an acute coronary syndrome: Insights from the RECLOSE 2-ACS study 347
Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis 346
Angiotensi-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinmeia increase first-trimester fetal-loss susceptibility 333
Current status of clopidogrel pharmacogenomics. 331
High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI 330
Bleeding events and maintenance dose of prasugrel: BLESS pilot study 318
Effect of blood hematocrit and erythrocyte deformability on adenosine 5' -diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy 317
Increased homocysteine and lipoprotein(a) levels highlight systemic atherosclerotic burden in patients with a history of acute coronary syndromes 317
Oxidative Modification of Fibrinogen Is Associated With Altered Function and Structure in the Subacute Phase of Myocardial Infarction. 313
Mediterranean versus vegetarian diet for cardiovascular disease prevention (the CARDIVEG study): Study protocol for a randomized controlled trial 313
Bioequivalence in the real world is a complex challenge: the case of clopidogrel 312
Inflammatory and antioxidant pattern unbalance in "clopidogrel-resistant" patients during acute coronary syndrome. 312
Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS gene polymorphisms in atrial fibrillation susceptibility 309
Platelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndrome 309
S38G single-nucleotide polymorphism at the KCNE1 locus is associated with heart failure 308
PPARgamma promoter polymorphisms and acute coronary syndromes 307
Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature 306
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis 304
High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion 298
Role of glycoprotein Ia gene polymorphisms in determinino platelet function in myocardial infarction patients undergoing percutaneous coronary intervention of dual antiplatelet treatment 290
Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis 288
Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility 288
Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy 287
Relationship between exercise capacity, endothelial progenitor cells and cytochemokines in patients undergoing cardiac rehabilitation. 285
Apolipoprotein(a) kringle-IV type 2 copy number variation is associated with venous thromboembolism 285
Symptomatic efficacy of buckwheat products in Non-Celiac Gluten Sensitivity (NCGS) 283
The balance between pro- and anti-infilammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients 282
Residual thrombin potential predicts cardiovascular death in acute coronary syndrome patients undergoing percutaneous coronary intervention 278
High sensitivity C-reactive protein predicts the development of new carotid artery plaques in older persons 277
Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk? 276
Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment 274
Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS(2) score 268
Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuroparty: a case-control study 267
Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function. 264
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis 260
NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort 245
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 243
Hign on treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting 242
Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome 242
Metabolomics by Nuclear Magnetic Resonance identifies patients with high risk of death within two years after a cardiovascular event: The case of the amiflorence II study 241
Role of biological markers for cerebral bleeding risk STRATification in patients with atrial fibrillation on oral anticoagulants for primary or secondary prevention of ischemic stroke (Strat-AF study): Study design and methodology 235
Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet) 230
Effects of a 3-month dietary intervention with a lacto-ovo-vegetarian diet on vitamin B-12 levels in a group of omnivores: results from the CARDIVEG (Cardiovascular Prevention with Vegetarian Diet) study 229
Prognostic value of sepsis-induced coagulation abnormalities: an early assessment in the emergency department 227
Cardiovascular benefits from ancient grain bread consumption: findings from a double-blinded randomized crossover intervention trial 222
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 218
Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study 215
ACE insertion/deletion, but not -240A>T polymorphism, modulates the severity in heart failure 214
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes 212
Gender effect on well-being of the oldest old: a survey of nonagenarians living in Tuscany: the Mugello study 211
ADAMTS-13 activity in the presence of elevated von Willebrand factor levels as a novel mechanism of residual platelet reactivity in high risk coronary patients on antiplatelet treatment 209
Aging process, adherence to Mediterranean diet and nutritional status in a large cohort of nonagenarians: Effects on endothelial progenitor cells 208
Prognostic relevance of GRACE risk score in Takotsubo syndrome 207
Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: The role of oxidative stress 207
ACE DD genotype: an independent predisposition factor to venous thromboembolism. 204
A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion. 203
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis 202
Effects of cryoablation and radiofrequency ablation on endothelial and blood clotting activation 202
RISK FACTORS FOR CARDIOVASCULAR DISEASE IN RENAL TRANSPLANT RECIPIENTS: NEW INSIGHTS 201
Can CHA2DS2-VASc and HAS-BLED Foresee the Presence of Cerebral Microbleeds, Lacunar and Non-Lacunar Infarcts in Elderly Patients With Atrial Fibrillation? Data From Strat-AF Study 200
Monoclonal Anti-PCSK9 Antibodies: Real-World Data 200
A time course study of high on treatment platelet reactivity in acute coronary syndrome male patients on dual antiplatelet therapy. 200
The genes that codify angiotensin converting enzyme and type 1 receptor for angiotensin II have a different effect on longevity 200
Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome 200
Platelet Reactivity in Hepatitis C Virus-Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome 199
Sars-CoV-2 induced coagulopathy and prognosis in hospitalized patients: A snapshot from Italy 198
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 197
Association of Body Fat With Health-Related Quality of Life and Depression in Nonagenarians: The Mugello Study 197
The high prevalence of thermolabile 5,10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD) 195
Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy 194
Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis 194
Mediterranean, but not lacto-ovo-vegetarian, diet positively influence circulating progenitor cells for cardiovascular prevention: The CARDIVEG study 194
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 194
Natural history of anti-PF4 antibodies in patients with vaccine-induced immune thrombocytopenia and thrombosis 192
Atrial septal defect closure and de novo migraine: Exclusive ticlopidine efficacy 192
The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists 191
Circulating endothelial and progenitor cells in age-related macular degeneration 191
High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI 189
Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. 188
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 188
Antiplatelets in acute coronary syndrome: personal perspectives. 188
Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism. 188
Altered fibrin susceptibility to plasmin-induced lysis in coronary artery disease patients: relationships with oxidative stress 188
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry 188
Analysis of Metabolite and Lipid Association Networks Reveals Molecular Mechanisms Associated with 3-Month Mortality and Poor Functional Outcomes in Patients with Acute Ischemic Stroke after Thrombolytic Treatment with Recombinant Tissue Plasminogen Activator 188
TISSUE FACTOR AND HOMOCYSTEINE LEVELS IN ISCHEMIC HEART DISEASE ARE ASSOCIATED WITH ANGIOGRAPHICALLY DOCUMENTED CLINICAL RECURRENCES AFTER CORONARY ANGIOPLASTY 187
Important risk factors for venous thromboembolism. Analysis of 758 patients studied at a thrombosis center 187
Clinical and echocardiographic predictors of postoperative atrial fibrillation in lung surgery: the role of left atrial remodelling 186
Genetic and nutritional factors determining circulating levels of lipoprotein(a): results of the "Montignoso Study" 186
Role of haemorheological factors in patients with retinal vein occlusion. 186
Totale 25.769
Categoria #
all - tutte 165.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.262 88 193 176 96 57 133 92 192 117 131 325 662
2022/20235.277 558 1.078 245 315 394 961 684 258 503 36 174 71
2023/20242.000 95 222 395 109 96 236 61 399 51 161 99 76
2024/202514.932 537 1.582 983 2.228 3.978 2.043 346 899 762 412 569 593
2025/202620.056 1.703 2.519 1.639 1.899 2.127 843 2.271 1.136 1.179 1.172 919 2.649
2026/202743 43 0 0 0 0 0 0 0 0 0 0 0
Totale 61.579